RENCÜZOĞULLARI, Ö. Et Al. 2016. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. APOPTOSIS , vol.21, no.10 , 1158-1178.

RENCÜZOĞULLARI, Ö., Arisan, E. D., YERLİKAYA, P. O., ÇOKER GÜRKAN, A., & Palavan-Unsal, N., (2016). mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. APOPTOSIS , vol.21, no.10, 1158-1178.

RENCÜZOĞULLARI, ÖZGE Et Al. "mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells," APOPTOSIS , vol.21, no.10, 1158-1178, 2016

RENCÜZOĞULLARI, ÖZGE Et Al. "mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells." APOPTOSIS , vol.21, no.10, pp.1158-1178, 2016

RENCÜZOĞULLARI, Ö. Et Al. (2016) . "mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells." APOPTOSIS , vol.21, no.10, pp.1158-1178.

@article{article, author={ÖZGE RENCÜZOĞULLARI Et Al. }, title={mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells}, journal={APOPTOSIS}, year=2016, pages={1158-1178} }